Login / Signup

Cerebrovascular Reactivity Impairment in Preclinical Alzheimer's Disease.

Mohammed AlwatbanDaniel L MurmanGregory R Bashford
Published in: Journal of neuroimaging : official journal of the American Society of Neuroimaging (2019)
In this exploratory pilot study, CVR was significantly decreased in preclinical, prodromal, and mild AD subjects as compared to the healthy group. Lower CVR in the preclinical AD group was detected using the new BHAI index but not the conventional BHI index.
Keyphrases
  • cell therapy
  • cognitive decline
  • stem cells